MedPath

Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter

Not Applicable
Conditions
Dislocated Intraocular Lens Into Vitreous
Retained Lens Fragments
Vitreous Hemorrhage
Vitrectomy
Retinal Detachment
Macular Holes
Epiretinal Membrane
Interventions
Device: 25-gauge, bevel-tip, 20000 cut per minute pars plana vitrectomy
Registration Number
NCT04404296
Lead Sponsor
Peregrine Eye and Laser Institute
Brief Summary

Report efficiency and clinical outcomes using 25-gauge, bevel-tip, 20000 cut per minute vitrectomy probe among eyes with various vitreo-retinal diseases

Detailed Description

We will evaluate the efficiency and clinical outcomes of pars plana vitrectomy using a 25-gauge, bevel-tip, 10 and 20000 cpm vitrectomy probe among eyes with 8 main surgical indications. Main outcome measures included efficiency measures, postoperative pain and complications.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All eyes undergoing pars plana vitrectomy with surgically amenable vitreoretinal disease.
Exclusion Criteria
  • History of prior PPV, glaucoma, scleral thinning, and active or recent history of (<3 months) ocular or extra-ocular infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
25-gauge 20000 PPV25-gauge, bevel-tip, 20000 cut per minute pars plana vitrectomyEyes will undergo pars plana vitrectomy using 25-gauge, bevel-tip, 20000 cut per minute vitrectomy probe
Primary Outcome Measures
NameTimeMethod
Operative time: Total6 months

From insertion of first trocar to removal of last trocar, measured in seconds using stopwatch

Secondary Outcome Measures
NameTimeMethod
Pain scoring6 months

Visual Analogue scale (0 to 4)

Adverse eventsUp to 3 months after surgery

Intra- and Postoperative complications

Number of times ancillary instruments placed in eye6 months

Count

Trial Locations

Locations (1)

Peregrine Eye and Laser Instittute

🇵🇭

Makati City, MM, Philippines

© Copyright 2025. All Rights Reserved by MedPath